Drugs and Human Memory (Part 2): Clinical, Theoretical, and Methodologic Issues

Anesthesiology

Volumn 100, Issue 5, 2004, Pages 1277-1297

  Ghoneim, Mohamed M ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; AMPHETAMINE; ANESTHETIC AGENT; ANTICONVULSIVE AGENT; ANXIOLYTIC AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAFFEINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CHOLINESTERASE INHIBITOR; COCAINE; DIAZEPAM; FENTANYL; FLUMAZENIL; ISOFLURANE; KETAMINE; MIDAZOLAM; NEUROLEPTIC AGENT; NITROUS OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PENTOBARBITAL; PROPOFOL; PROPRANOLOL; PSYCHOTROPIC AGENT; SEROTONIN AGONIST; THIOPENTAL; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; ZALEPLON;

ALZHEIMER DISEASE; AMNESIA; ANTEROGRADE AMNESIA; ARTIFACT; BEHAVIOR; BIPOLAR DISORDER; BLOOD BRAIN BARRIER; BRAIN BLOOD FLOW; BRAIN REGION; CHRONOPHARMACOLOGY; CLINICAL TRIAL; COGNITIVE DEFECT; DOSE RESPONSE; DRUG ABUSE; DRUG ALCOHOL INTERACTION; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG MECHANISM; DRUG METABOLISM; DRUG SENSITIZATION; DRUG TOLERANCE; DRUG TRANSPORT; ELECTROCONVULSIVE THERAPY; ELECTROENCEPHALOGRAPHY; HUMAN; LONG TERM CARE; MAGNETOENCEPHALOGRAPHY; MAJOR DEPRESSION; MEMORY CONSOLIDATION; MEMORY DISORDER; MENTAL STRESS; METHODOLOGY; NEUROANATOMY; NEUROLOGICAL COMPLICATION; NEUROTOXICITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHARMACODYNAMICS; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECOGNITION; REVIEW; SEDATION; SIDE EFFECT; TASK PERFORMANCE; TRANSIENT GLOBAL AMNESIA; WORKING MEMORY;

ANIMALS; CLINICAL TRIALS; HUMANS; MEMORY; MODELS, NEUROLOGICAL; PHARMACEUTICAL PREPARATIONS; RESEARCH DESIGN;

EID: 2142643006     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200405000-00033     Document Type: Review

References (256)

1. References 1-116 appear in part 1 of this article in the April issue of the Journal (ANESTHESIOLOGY 2004; 100:987-1002); some of those references are re-cited in part 2.
2. Mewaldt SP, Ghoneim MM, Choi WW, Korttila K, Peterson RC: Nitrous oxide and human state-dependent memory. Pharmacol Biochem Behav 1988; 30:83-7
3. Eich JE, Birnbaum IM: Repetition, cuing and state-dependent memory. Mem Cogn 1982; 10:103-14
4. Hieronymus AN, Lindquist EF, Hoover HD: Manual for school administrators, Iowa Tests of Basic Skills. Chicago, Riverside, 1982
5. Davis KL, Hollister LE, Overall J, Johnson A, Train K: Physostigmine: Effects on cognition and affect in normal subjects. Psychopharmacology 1976; 51:23-7
6. Davis KL, Mohs RC, Tinklenberg JR, Pfefferbaum A, Hollister LE, Kopell BS: Physostigmine: Improvement of long-term memory processes in normal humans. Science 1978; 201:272-4
7. Izquierdo I: Nimodipine and the recovery of memory. Trends Pharmacol Sci 1990; 11:309-10
8. Kaplan GB, Tai NT, Greenblatt DJ, Shader RI: Caffeine-induced behavioural stimulation is dose- and concentration-dependent. Br J Pharmacol 1990; 100:435-9
9. Bruce M, Scott N, Lader M, Marks V: The psychopharmacological and electrophysiological effects of single doses of caffeine in healthy human subjects. Br J Clin Pharmacol 1986; 22:81-7
10. McGaugh JL: Involvement of hormonal and neuromodulatory systems in the regulation of memory storage. Annu Rev Neurosci 1989; 12:255-64
11. Izquierdo I: Different forms of post-training memory processing. Behav Neural Biol 1989; 51:171-202
12. Ashton H, Marsh VR, Millman JE, Rawlins MD, Telford R, Thompson JW: Biphasic dose-related responses of the CNV (contingent negative variation) to intravenous nicotine in man. Br J Clin Pharmacol 1980; 10:579-89
13. Ghoneim MM, Hinrichs JV, Chiang CK, Loke WH: Pharmacokinetic and pharmacodynamic interactions between caffeine and diazepam. J Clin Psychopharmacol 1986; 6:75-80
14. Ellinwood EH Jr, Linnoila M, Easler ME, Molter DW: Profile of acute tolerance to three sedative anxiolytics. Psychopharmacology 1983; 79:137-41
15. Ambre JJ, Belknap SM, Nelson J, Ruo TI, Shin SG, Atkinson AJ: Acute tolerance to cocaine in humans. Clin Pharmacol Ther 1988; 44:1-8
16. Zwyghuizen-Doorenbos A, Roehrs TA, Lipschutz L, Timms V, Roth T: Effects of caffeine on alertness. Psychopharmacology 1990; 100:36-9
17. Griffiths RR, Woodson PP: Caffeine dependence: A review of human and laboratory animal studies. Psychopharmacology 1988; 94:437-51
18. Tatum AL, Seevers MH: Experimental cocaine addiction. J Pharmacol Exp Ther 1929; 36:401-10
19. Shuster L, Yu G, Bates A: Sensitization to cocaine stimulation in mice. Psychopharmacology 1977; 52:185-90
20. Holford NH, Sheiner LB: Understanding the dose-effect relationship: Clinical application of pharmacokinetic-pharmacodynamic models. Clin Pharmacokinet 1981; 6:429-53
21. Laurijssens BE, Greenblatt DJ: Pharmacokinetic-pharmacodynamic relationships for benzodiazepines. Clin Pharmacokinet 1996; 30:52-76
22. Campbell DB: The use of kinetic-dynamic interactions in the evaluation of drugs. Psychopharmacology 1990; 100:433-50
23. Veselis RA, Reinsel RA, Feshchenko VA, Wronski M: The comparative amnestic effects of midazolam, propofol, thiopental, and fentanyl at equisedative concentrations. ANESTHESIOLOGY 1997; 87:749-64
24. Stanski DR, Hudson PJ, Homer TD, Saidman LJ, Meathe E: Pharmacometrics: Pharmacodynamic modeling of thiopental anesthesia. J Pharmacokinet Biopharm 1984; 12:223-40
25. Koch-Weser J, Sellers EM: Binding of drugs to serum albumin: 1. N Engl J Med 1976; 294:311-6
26. Ghoneim MM, Pandya HB, Kelly SE, Fischer LJ, Cory RJ: Binding of thiopental to plasma proteins: Effects of distribution in the brain and heart. ANESTHESIOLOGY 1976; 45:635-9
27. Bührer M, Maitre PO, Crevoisier C, Stanski DR: Electroencephalographic effects of benzodiazepines: II. Pharmacodynamic modeling of the electroencephalographic effects of midazolam and diazepam. Clin Pharmacol Ther 1990; 48:555-67
28. Schulz R, Reimann IW: Practice effect of volunteers in repeated psychometric testing: How to handle this intervening variable in clinical pharmacology studies? Methods Find Exp Clin Pharmacol 1988; 10:657-61
29. Yamamoto I, Ho IK, Loh HH: The antagonistic effects of 5-ethyl-5-(3-hydroxy-1-methylbutyl)-barbituric acid on peritobarbital narcosis in both naive and tolerant mice. Life Sci 1978; 22:1103-12
30. Dingemanse J, Thomassen D, Mentink BH, Danhof M: Strategy to assess the role of (inter)active metabolites in pharmacodynamic studies in-vivo: A model study with heptabarbital. J Pharm Pharmacol 1988; 40:552-7
31. Sheiner LB, Stanski DR, Vozeh S, Miller RD, Ham J: Simultaneous modeling of pharmacokinetics and pharmacodynamics: Application to d-tubocurarine. Clin Pharmacol Ther 1979; 25:358-71
32. Green JF, McElholm A, King DJ: A comparison of the sedative and amnestic effects of chlorpromazine and lorazepam. Psychopharmacology (Berl) 1996; 128:67-73
33. Curran HV, Poovibunsuk P, Dalton J, Lader MH: Differentiating the effects of centrally acting drugs on arousal and memory: An event-related potential study of scopolamine, lorazepam and diphenhydramine. Psychopharmacology (Berl) 1998; 135:27-36
34. Ghoneim MM, Mewaldt SP, Berie JL, Hinrichs JV: Memory and performance effects of single and 3-week administration of diazepam. Psychopharmacology (Berl) 1981; 73:147-51
35. Curran HV, Bond A, O'Sullivan G, Bruce M, Marks I, Lelliot P, Shine P, Lader M: Memory functions, alprazolam and exposure therapy: A controlled longitudinal study of agoraphobia with panic disorder. Psychol Med 1994; 24:969-76
36. Lucki I, Rickels K, Geller AM: Chronic use of benzodiazepines and psychomotor and cognitive test performance. Psychopharmacology (Berl) 1986; 88:426-33
37. Tata PR, Rollings J, Collins M, Pickering A, Jacobson RR: Lack of cognitive recovery following withdrawal from long-term benzodiazepine use. Psychol Med 1994; 24:203-13
38. Curran HV, Birch B: Differentiating the sedative, psychomotor and amnesic effects of benzodiazepines: A study with midazolam and the benzodiazepine antagonist, flumazenil. Psychopharmacology (Berl) 1991; 103:519-23
39. Hommer D, Weingartner H, Breier A: Dissociation of benzodiazepine-induced amnesia from sedation by flumazenil pretreatment. Psychopharmacology (Berl) 1993; 112:455-60
40. Roache JD, Griffiths RR: Comparison of triazolam and pentobarbital: Performance impairment, subjective effects and abuse liability. J Pharmacol Exp Ther 1985; 234:120-33
41. Rich JB, Brown GG: Selective dissociations of sedation and amnesia following ingestion of diazepam. Psychopharmacology (Berl) 1992; 106:346-50
42. Weingartner HJ, Sirocco K, Rawlings R, Joyce E, Hommer D: Dissociations in the expression of the sedative effects of triazolam. Psychopharmacology (Berl) 1995; 119:27-33
43. Veselis RA, Reinsel RA, Feshchenko VA: Drug-induced amnesia is a separate phenomenon from sedation: Electrophysiologic evidence. ANESTHESIOLOGY 2001; 95:896-907
44. Ghoneim MM, Mewaldt SP: Benzodiazepines and human memory: A review. ANESTHESIOLOGY 1990; 72:926-38
45. Curran HV: Benzodiazepines, memory and mood: A review. Psychopharmacology (Berl) 1991; 105:1-8
46. Kandel L, Chortkoff BS, Sonner J, Laster MJ, Eger EI II: Nonanesthetics can suppress learning. Anesth Analg 1996; 82:321-6
47. Sonner JM, Li J, Eger EI II: Desflurane and the nonimmobilizer 1,2-dichlorohexafluorocyclobutane suppress learning by a mechanism independent of the level of unconditioned stimulation. Anesth Analg 1998; 87:200-5
48. Dutton RC, Rampil IJ, Eger EI II: Inhaled nonimmobilizers do not alter the middle latency auditory-evoked response of rats. Anesth Analg 2000; 90:213-7
49. Stern E, Silbersweig DA: Advances in functional neuroimaging methodology for the study of brain systems underlying human neuropsychological function and dysfunction. J Clin Exp Neuropsychol 2001; 23:3-18
50. Schacter DL, Wagner AD, Buckner RL: Memory systems of 1999, The Oxford Handbook of Memory. Edited by Tulving E, Craik FIM. New York, Oxford University Press, 2000, pp 627-43
51. Coull JT, Frith CD, Dolan RJ, Frackowiak RS, Graspy PM: The neural correlates of the noradrenergic modulation of human attention, arousal and learning. Eur J Neurosci 1997; 9:589-98
52. O'Leary DS, Block RI, Koeppel JA, Flaum M, Schultz SK, Andreasen NC, Boles Ponto L, Watkins GL, Hurtig RR, Hichwa RD: Effects of smoking marijuana on brain perfusion and cognition. Neuropsychopharmacology 2002; 26:802-16
53. Alkire MT, Pomfrett CJD, Haler RJ, Gianzero MV, Chan CM, Jacobsen BP, Fallon JH: Functional brain imaging during anesthesia in humans: Effects of halothane on global and regional cerebral glucose metabolism. ANESTHESIOLOGY 1999; 90:701-9
54. Veselis RA, Reinsel RA, Feshchenko VA, Dnistrian AM: A neuroanatomical construct for the amnesic effects of propofol. ANESTHESIOLOGY 2002; 97:329-37
55. Posner MI, Raichle ME: Images of Mind. New York, Scientific American Library, 1994, pp 53-81, 228-31
56. Block RI, O'Leary DS, Hichwa RD, Augustinack JC, Boles Ponto LL, Ghoneim MM, Arndt S, Hurtig RR, Watkins GL, Hall JA, Nathan PE, Anedreasen NC: Effects of frequent marijuana use on memory-related regional cerebral blood flow. Pharmacol Biochem Behav 2002; 72:237-50
57. Price CJ, Friston KJ: Cognitive conjunction: A new approach to brain activation experiments. Neuroimage 1997; 5:261-70
58. Nyberg L, Cabeza R: Brain imaging of memory, The Oxford Handbook of Memory. Edited by Tulving E, Craik FIM. New York, Oxford University Press, 2000, pp 501-19
59. Block RI, O'Leary DS, Enrhardt JC, Augistinack JC, Ghoneim MM, Arndt S, Hall JA: Effects of frequent marijuana use on brain tissue volume and composition. Neuroreport 2000; 11:491-6
60. Hurtig RR, Hichwa RD, O'Leary DS, Ponto LLB, Narayana S, Watkins GL, Andreasen NC: Effects of timing and duration of cognitive activation in [15O] water PET studies. J Cereb Blood Flow Metab 1994; 14:423-30
61. Dale AM, Halgren E: Spatiotemporal mapping of brain activity by integration of multiple imaging modalities. Curr Opin Neurobiol 2001; 11:202-8
62. Mazziotta JC, Toga AW, Evans A, Fox P, Lancaster J: A probabilistic atlas of the human brain: Theory and rationale for its development. The International Consortium for Brain Mapping (ICBM). Neuroimage 1995; 2:89-101
63. 15O PET Cognitive activation studies. J Neuropsychiatry 1995; 7:155-68
64. Friston KJ, Homes AP, Worsley KJ, Poline J-P, Frith CD, Frackowiak RSJ: Statistical parametric maps in functional imaging: A general linear approach. Hum Brain Mapp 1995; 2:189-210
65. Tulving E, Kapur S, Craik FIM, Moscovitch M, Houle S: Hemispheric encoding/retrieval asymmetry in episodic memory: Positron emission tomography findings. Proc Natl Acad Sci U S A 1994; 91:2016-20
66. Nyberg L, Cabeza R, Tulving E: PET studies of encoding and retrieval: The HERA model. Psychon Bull Rev 1996; 3:135-48
67. Miller MB, Kingstone A, Gazzaniga MS: Hemispheric encoding asymmetry is more apparent than real. J Cogn Neurosci 2002; 14:702-8
68. Desgranges B, Baron JC, Eustache F: The functional neuroanatomy of episodic memory: The role of the frontal lobes, the hippocampal formation, and other areas. Neuroimage 1998; 8:198-213
69. Lepage M, Ghaffar O, Nyberg L, Tulving E: Prefrontal cortex and episodic memory retrieval mode. Proc Natl Acad Sci U S A 2000; 97:506-11
70. Yancy SW, Phelps EA: Functional neuroimaging and episodic memory: A perspective. J Clin Exp Neuropsychol 2001; 23:32-48
71. Haxby JV, Ungerleider LG, Horwitz B, Maisog JM, Rapoport SL, Grady CL: Face encoding and recognition in the human brain. Proc Natl Acad Sci U S A 1996; 93:922-7
72. Kapur S, Tulving E, Cabeza R, McIntosh AR, Houle S, Craik FIM: The neural correlates of intentional learning of verbal materials: A PET study in humans. Cogn Brain Res 1996; 4:243-9
73. Cahill L, Haler RJ, Fallon J, Alkire MT, Tang C, Keator D, Wu J, McGaugh JL: Amygdala activity at encoding correlated with long-term free recall of emotional information. Proc Natl Acad Sci U S A 1996; 93:8016-21
74. Hamann SB, Ely TD, Grafton ST, Kilts CD: Amygdala activity related to enhanced memory for pleasant and aversive stimuli. Nat Neurosci 1999; 2:289-93
75. Cabeza R, Nyberg L: Imaging cognition: An empirical review of PET studies with normal subjects. J Cogn Neurosci 1997; 9:1-26
76. Schacter DL, Buckner RL, Koutstaal W: On the relations among priming, conscious recollection, and intentional retrieval: Evidence from neuroimaging research. Neurobiol Learn Mem 1998; 70:284-303
77. Buckner RL, Tulving E: Neuroimaging studies of memory: Theory and recent PET results, Handbook of Neuropsychology, vol 10. Edited by Boller F, Grafman J. Amsterdam, Elsevier, 1995, pp 439-66
78. Smith EE, Jonides J: Neuroimaging analyses of human working memory. Proc Natl Acad Sci U S A 1998; 95:12061-8
79. Fiez JA: Bridging the gap between neuro imaging and neuropsychology: Using working memory as a case-study. J Clin Exp Neuropsychol 2001; 23:19-31
80. Gabrieli JDE: Cognitive neuroscience of human memory. Annu Rev Psychol 1998; 49:87-115
81. Posner MI, Raichle ME: Images of Mind. New York, Scientific American Library, 1994, p 127
82. Buchel C, Morris J, Dolan RJ, Friston KJ: Brain systems mediating aversive conditioning: An event-related fMRI study. Neuron 1998; 20:947-57
83. LaBar KS, Gatenby C, Gore JC, LeDoux JE, Phelps EA: Amygdalo-cortical activation during conditioned fear acquisition and extinction: A mixed trial fMRI study. Neuron 1998; 20:937-45
84. Ivry RB, Fiez JA: Cerebellar contribution to thought and imagery, The New Cognitive Neurosciences. Edited by Gazzaniga MS. Cambridge, MIT Press, 1998, pp 999-1018
85. Horwitz B, McIntosh AR, Haxby JV, Grady CL: Network analysis of brain cognitive function using metabolic and blood flow data. Behav Brain Res 1995; 66:187-93
86. Cabeza R, McIntosh AR, Tulving E, Nyberg L, Grady CL: Age-related differences in effective neural connectivity during encoding and recall. Neuroreport 1997; 8:3479-83
87. Petersson KM, Reis A, Ingvar M: Cognitive processing in literate and illiterate subjects: A review of some recent behavioral and functional neuroimaging data. Scand J Psychol 2001; 42:251-67
88. McIntosh AR, Gonzalez-Lima F: Structural equation modeling and its application to network analysis in functional brain imaging. Hum Brain Mapp 1994; 2:2-22
89. Fuster JM: Network memory. Trends Neurosci 1997; 20:451-9
90. McIntosh AR: Mapping cognition to the brain through neural interactions. Memory 1999; 7:523-48
91. Jones JG, Aggarwal S: Monitoring the depth of anesthesia, Awareness during Anesthesia. Edited by Ghoneim MM. Oxford, Butterworth-Heineman, 2001, pp 69-91
92. Andrade J: Learning during sedation, anesthesia and surgery, Awareness during Anesthesia. Edited by Ghoneim MM. Oxford, Butterworth-Heinemann, 2001, pp 93-102
93. Rusted JM, Warburton DM: The effects of scopolamine on working memory in healthy volunteers. Psychopharmacology 1988; 96:145-52
94. Gorissen MEE, Eling PATM: Dual task performance after diazepam intake: Can resource depletion explain the benzodiazepine-induced amnesia? Psychopharmacology 1998; 138:354-61
95. Rusted JM: Cholinergic blockade: Are we asking the right questions? J Psychopharmacol 1994; 8:54-9
96. Fang JC, Hinrichs JV, Ghoneim MM: Diazepam and memory: Evidence for spared memory function. Pharmacol Biochem Behav 1987; 28:347-52
97. Hirshman E, Passannante A, Arndt J: Midazolam amnesia and conceptual processing in implicit memory. J Exp Psychol (Gen) 2001; 130:453-65
98. Danion JM, Zimmermann M-A, Willard-Schroeder D, Grange D, Singer L: Diazepam induces a dissociation between explicit and implicit memory. Psychopharmacology 1989; 99:238-43
99. Block RI, Ghoneim MM, Pathak D, Kumar V, Hinricks JV: Effects of a subanesthetic concentration of nitrous oxide on overt and covert assessments of memory and associative processes. Psychopharmacology 1988; 96:324-31
100. Block RI, Ghoneim MM, Sum-Ping ST, Ali MA: Human learning during general anaesthesia and surgery. Br J Anaesth 1991; 66:170-8
101. Ghoneim MM, Block RI, Sum-Ping ST, El-Zahaby HM, Hinricks JV: The interactions of midazolam and flumazenil on human memory and cognition. ANESTHESIOLOGY 1993; 79:1183-92
102. Ghoneim MM, Block RI, Dhanaraj VJ: Interaction of a subanaesthetic concentration of isoflurane with midazolam: Effects on responsiveness, learning and memory. Br J Anaesth 1998; 80:581-7
103. Danion JM, Zimmermann MA, Willard-Schoeder D, Grange D, Welsch M, Imbs JL, Singer L: Effects of scopolamine, trimipramine and diazepam on explicit memory and repetition priming in healthy volunteers. Psychopharmacology 1990; 102:422-4
104. Brown MW, Brown J, Bowes J: Absence of priming coupled with substantially preserved recognition in lorazepam induced amnesia. Q J Exp Psychol 1989; 41A:599-617
105. Stewart SH, Rioux GF, Connolly JF, Dunphy SC, Teehan MD: Effects of oxazepam and lorazepam on implicit and explicit memory: Evidence for possible influences of time course. Psychopharmacology 1996; 128:139-49
106. Squire LR, Kandel ER: Memory, From Mind to Molecules. New York, Scientific American Library, 2000, pp 176-8
107. Petersen S, Van Mier H, Fiez JA, Raichle ME: The effects of practice on the functional anatomy of task performance. Proc Natl Acad Sci U S A 1998; 95:853-60
108. Block RI, Ghoneim MM, Hinrichs JV, Kumar V, Pathak D: Effects of a subanaesthetic concentration of nitrous oxide on memory and subjective experience: Influence of assessment procedures and types of stimuli. Hum Psychopharmacol 1988; 3:257-65
109. Block RI, Farinpour R, Braverman K: Effects of marijuana smoking on cognition and their relationship to smoking technique. Pharmacol Biochem Behav 1992; 43:907-17
110. Birnbaum IM, Parker ES: Acute effects of alcohol on storage and retrieval, Alcohol and Human Memory. Edited by Birnbaum IM, Parker ES. Hillsdale, New Jersey, Lawrence Erlbaum, 1977, pp 99-108
111. Hinrichs JV, Mewaldt SP, Ghoneim MM, Berie JL: Diazepam and learning: Assessment of acquisition deficits. Pharmacol Biochem Behav 1982; 17:165-70
112. Hinrichs JV, Ghoneim MM, Mewaldt SP: Diazepam and memory: Retrograde facilitation produced by interference reduction. Psychopharmacology 1984; 84:158-62
113. Adam N, Castro AD, Clark DL: State-dependent learning with a general anesthetic (isoflurane) in man. TTT J Life Sci 1974; 4:125-34
114. Curran VH, Morgan C: Cognitive, dissociative and psychotogenic effects of ketamine in recreational users on the night of drug use and 3 days later. Addiction 2000; 95:575-90
115. Gardiner JM, Richardson-Klavehn A: Remembering and knowing, The Oxford Handbook of Memory. Edited by Tulving E, Craik FiM. New York, Oxford University Press, 2000, pp 229-44
116. Curran HV, Gardiner JM, Java R, Allen DJ: Effects of lorazepam on recollective experience in cognition memory. Psychopharmacology 1993; 110:374-8
117. Mintzer MZ, Griffiths RR: Acute effects of triazolam on false recognition. Mem Cogn 2000; 28:1357-65
118. Nichols JM, Martin F, Kirkby KC: A comparison of the effect of lorazepam on memory in heavy and low social drinkers. Psychopharmacology 1993; 112:475-82
119. Balota DA, Dolan PO, Duchek JM: Memory changes in healthy older adults, The Oxford Handbook of Memory. Edited by Tulving E, Craik FIM. New York, Oxford University Press, 2000, pp 395-409
120. Craik FIM, Jennings JM: Human Memory, The Handbook of Aging and Cognition. Edited by Craik FIM, Salthouse TA. Hillsdale, New Jersey, Erlbaum, 1992, pp 51-110
121. Craik FIM, McDowd JM: Age differences in recall and recognition. J Exp Psychol (Learn Mem Cogn) 1987; 13:474-9
122. LaVoie D, Light LL: Adult age differences in repetition priming: A meta-analysis. Psychol Aging 1994; 9:539-53
123. Hinrichs JV, Ghoneim MM: Diazepam, behavior, and aging: Increased sensitivity or lower baseline performance? Psychopharmacology 1987; 92:100-5
124. Hughes LM, Wasserman EA, Hinrichs JV: Chronic diazepam administration and appetitive discrimination learning: Acquisition versus steady-state performance in pigeons. Psychopharmacology 1984; 84:318-22
125. Moon Y, Ghoneim MM, Gormezano I: Nitrous oxide: Sensory, motor, associative and behavioral tolerance effects in classical conditioning of the rabbit nictitating membrane response. Pharmacol Biochem Behav 1994; 47:523-9
126. Weingartner H: Human state-dependent learning, Drug Discrimination and State-Dependent Learning. Edited by Ho BT, Richards D III, Chute D. New York, Academic Press, 1977, pp 361-82
127. Petersen RC, Ghoneim MM: Diazepam and human memory: Influence on acquisition, retrieval, and state-dependent learning. Prog Neuropsychopharmacol 1980; 4:81-9
128. Buffett-Jerrott SE, Stewart SH, Teehan MD: A further examination of the time-dependent effects of oxazepam and lorazepam on implicit and explicit memory. Psychopharmacology 1998; 138:344-53
129. Cahill L: Neurobiology of memory for emotional events: Converging evidence from infrahuman and human studies. Cold Spring Harb Symp Quant Biol 1996; LXI:259-64
130. Murphy ST, Monahan JL, Zajonc RB: Additivity of nonconscious affect: Combined effects of priming and exposure. J Pers Soc Psychol 1995; 69:589-602
131. Cahill L, Babinsky R, Markowitsch HJ, McGaugh JL: The amygdala and emotional memory. Nature 1995; 377:295-6
132. Schacter DL: The Seven Sins of Memory. New York, Houghton Mifflin Co., 2001
133. Schacter DL, Verfaellie M, Anes MD: Illusory memories in amnesic patients: Conceptual and perceptual false recognition. Neuropsychology 1997; 11:331-42
134. Mewaldt SP, Ghoneim MM: The effects and interactions of scopolamine, physostigmine and methamphetamine on human memory. Pharmacol Biochem Behav 1979; 10:205-10
135. Block RI, Wittenborn JR: Marijuana effects on semantic memory: Verification of common and uncommon category members. Psychol Rep 1984; 55:503-12
136. Gorissen MEE, Curran HV, Eling PATM: Proactive interference and temporal context encoding after diazepam intake. Psychopharmacology 1998; 138:334-43
137. Levkovitz Y, Caftori R, Avital A, Richter-Levin G: The SSRIs drug Fluoxetine, but not the noradrenergic tricyclic drug Desipramine, improves memory performance during acute major depression. Brain Res Bull 2002; 58:345-50
138. Harmer CJ, Bhagwagar Z, Cowen PJ, Goodwin GM: Acute administration of citalopram facilitates memory consolidation in healthy volunteers. Psychopharmacologia 2002; 163:106-10
139. Meneses A: Could the 5-HT1B receptor inverse agonism affect learning consolidation? Neurosci Behav Rev 2001; 25:193-201
140. Helmstaedter C, Kurthen M: Memory and epilepsy: Characteristics, course, and influence of drugs and surgery. Curr Opin Neurol 2001; 14:211-6
141. Brunbech L, Sabers A: Effect of antiepileptic drugs on cognitive function in individuals with epilepsy: A comparative review of newer versus older agents. Drugs 2002; 62:593-604
142. Kuperberg G, Heckers S: Schizophrenia and cognitive function. Curr Opin Neurobiol 2000; 10:205-10
143. Galletly CA, Clark CR, MacFarlane AC: Treating cognitive dysfunction in patients with schizophrenia. J Psychiatry Neurosci 2000; 25:117-24
144. Rollnik JD, Borsutzky M, Huber TJ, Mogk H, Seifert J, Emrich HM, Schneider U: Short-term cognitive improvement in schizophrenics treated with typical and atypical neuroleptics. Neuropsychobiology 2002; 45:74-80
145. Bilder RM, Goldman RS, Volavka J, Czobor P, Hoptman M, Sheitman B, Lindenmayer JP, Citrome L, McEvoy J, Kunz M, Chakos M, Cooper TB, Horowitz TL, Lieberman JA: Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder. Am J Psychiatry 2002; 159:1018-28
146. Kulisevsky J: Role of dopamine in learning and memory: Implications for the treatment of cognitive dysfunction in patients with Parkinson's disease. Drugs Aging 2000; 16:365-79
147. Kimberg DY, Aguirre GK, Lesse J, D'Esposito M: Cortical effects of bromocriptine, a D-2 dopamine receptor agonist, in human subjects, revealed by fMRI. Hum Brain Mapp 2001; 12:246-57
148. Mehta MA, Swainson R, Ogilvie AD, Sahakian J, Robbins TW: Improved short-term spatial memory but impaired reversal learning following the dopamine D(2) agonist bromocriptine in human volunteers. Psychopharmacologia 2001; 159:10-20
149. Perlmuter LC, Hakami MK, Hodgson Harrington C, Ginsberg J, Katz J, Singer DE, Nathan DM: Decreased cognitive function in ageing non insulin-dependent diabetic patients. Am J Med 1984; 77:1043-8
150. Perlmuter LC, Tun PA, Sizer N, McGlinchey RE, Nathan DM: Age and diabetes related changes in verbal fluency. Exp Aging Res 1987; 13:9-14
151. Tun PA, Perlmuter LC, Russo P, Nathan DM: Memory self-assessment and performance in aged diabetics and non-diabetics. Exp Aging Res 1987; 13:151-7
152. Mooradian AD, Perryman K, Fitten J, Kavonian GD, Morley JE: Cortical function in elderly non-insulin dependent diabetic patients: Behavioural and electrophysiologic studies. Arch Intern Med 1988; 148:1369-72
153. Bent N, Rabbitt P, Metcalfe D: Diabetes mellitus and the rate of cognitive ageing. Br J Clin Psychol 2000; 39:349-62
154. Reus VI, Wolkowitz OM: Antiglucocorticoid drugs in the treatment of depression. Expert Opin Investig Drugs 2001; 10:1789-96
155. Schopfer U, Schoeffter P, Bischoff SF, Nozulak J, Feuerbach D, Floersheim P: Toward selective Erbeta agonists for central nervous system disorders: Synthesis and characterization of aryl benzthiophenes. J Med Chem 2002; 45:1399-401
156. Anthony M, Williams JK, Dunn BK: What would be the properties of an ideal SERM? Ann N Y Acad Sci 2001; 949:261-78
157. Shaywitz SE, Shaywitz BA, Pugh KR, Fulbright RK, Skudlarski P, Mencl WE, Constable RT, Naftolin F, Palter SF, Marchione KE, Katz L, Shankweiler DP, Fletcher JM, Lacadie C, Keltz M, Gore JC: Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks. JAMA 1999; 281:1197-202
158. Green HJ, Pakenham KI, Headiey BC, Yaxley J, Nicol DL, Mactaggart PN, Swanson C, Watson RB, Gardiner RA: Altered cognitive function in men treated for prostate cancer with luteinizing hormone-releasing hormone analogues and cyproterone acetate: A randomized controlled trial. Br J Urol 2002; 90:427-32
159. Parrot AC, Hindmarsch I: Clobazam: A benzodiazipine derivative: Effects upon human psychomotor performance under different levels of task reinforcement. Arch Int Pharmacodyn Ther 1978; 232:261-8
160. Nakano S, Ogawa N, Kawazu Y, Osato E: Effects of antianxiety drug and personality on stress-inducing psychomotor performance test. J Clin Pharmacol 1978; 18:125-30
161. Ghoneim MM, Mewaldt SP, Hinrichs JV: Dose-response analysis of the behavioral effects of diazepam: II. Psychomotor performance, cognition and mood. Psychopharmacology 1984; 82:296-300
162. Linnoila M, Erwin CW, Brendle A, Simpson D: Psychomotor effects of diazepam in anxious patients and healthy volunteers. J Clin Psychopharmacol 1983; 3:88-96
163. Ghoneim MM, Hinrichs JV, Noyes R Jr, Anderson DJ: Behavioral effects of diazepam and propranolol in patients with panic disorder and agoraphobia. Neuropsychobiology 1984; 11:229-35
164. Chojnacka-Wojcik E, Koodzinska A, Pilc A: Glutamate receptor ligands as anxiolytics. Curr Opin Investig Drugs 2001; 2:1112-9
165. Möhler H, Fritschy JM, Rudolph M: A new benzodiazepine pharmacology. J Pharmacol Exp Ther 2002; 300:2-8
166. Roth T: The relationship between psychiatric diseases and insomnia. Int Clin Pract 2001; 116(suppl):3-8
167. Howard SK, Gaba DM, Smith BE, Weinger MB, Herndon C, Keshavacharya S, Rosekind MR: Simulation study of rested versus sleep-deprived anesthesiologists. ANESTHESIOLOGY 2003; 98:1345-55
168. Roth T, Roehrs TA: Issues in the use of benzodiazepine therapy. J Clin Psychiatry 1992; 53(suppl):14-8
169. Vermeeren A, Danjou PE, O'Hanlon JF: Residual effects of evening and middle-of-the-night administration of zaleplon 10 and 20 mg on memory and actual driving performance. Hum Psychopharmacol Clin Exp 1998; 13:S98-S107
170. Danjou P, Paty I, Fruncillo R, Worthington Munnuh P, Cevallous W, Martin P: A comparison of the residual effects of zaleplon and zolpidem following administration 5 to 2 h before awakening. Br J Clin Pharmacol 1999; 48:367-74
171. Fry J, Scharf M, Mangano R, Fujimori M, Zaleplon Clinical Study Group: Zaleplon improves sleep without producing rebound effects in outpatients with insomnia. Int Clin Psychopharmacol 2000; 15:141-52
172. Sandin RH, Enlund G, Samuelsson P, Lennmarken C: Awareness during anesthesia: A prospective case study. Lancet 2000; 355:707-11
173. Ghoneim MM: Awareness during anesthesia, Awareness during Anesthesia. Edited by Ghoneim MM. Oxford, Butterworth-Heineman, 2001, pp 1-22
174. Ghoneim MM: Implicit memory for events during anesthesia, Awareness during Anesthesia. Edited by Ghoneim MM. Oxford, Butterworth-Heineman, 2001, pp 23-68
175. Rundshagen I, Schnabel K, Schulte am Esch J: Recovery of memory after general anaesthesia: Clinical findings and somatosensory evoked responses. Br J Anaesth 2002; 88:362-8
176. Ghoneim MM, Hinrichs JV, O'Hara MW, Mehta MP, Pathak D, Kumar V, Clark CR: Comparison of psychologic and cognitive functions after general or regional anesthesia. ANESTHESIOLOGY 1988; 69:507-15
177. Riis J, Lomholt B, Haxholdt O, Kehlet H, Valentin N, Danielsen U, Dyrberg V: Immediate and long-term mental recovery from general versus epidural anesthesia in elderly patients. Acta Anaesthesiol Scand 1983; 27:44-9
178. Tzabar Y, Asbury AJ, Millar K: Cognitive failures after general anesthesia for day-case surgery. Br J Anaesth 1996; 76:194-7
179. Millar K: The effects of anaesthetic and analgesic drugs, Handbook of Human Performance. Vol 2. Edited by Smith AP, Jones DM. London, Academic Press, 1992, 337-85
180. Hickey S, Asbury AJ, Millar K: Psychomotor recovery after outpatient anaesthesia: Individual impairment may be masked by group analysis. Br J Anaesth 1991; 66:345-52
181. Davison LA, Steinhelber JC, Eger EI, Stevens WC: Psychological effects of halothane and enflurane anesthesia. ANESTHESIOLOGY 1975; 43:313-24
182. Kehlet H: Stress-free surgery and anaesthesia. Acta Anaesthesiol Scand 1979; 23:503-4
183. Jones C, Griffiths RD, Humphris G: Disturbed memory and amnesia related to intensive care. Memory 2000; 8:79-94
184. Wood T, Donegan J: Transient global amnesia following general anesthesia. ANESTHESIOLOGY 1985; 62:807-09
185. Ghoneim MM: Transient global amnesia: A cause for postanesthetic memory disorder (letter). Anesth Analg 1998; 87:977-82
186. Kritchevsky M, Zouzounis J, Squire LR: Transient global amnesia and functional retrograde amnesia: Contrasting examples of episodic memory loss. Philos Trans R Soc Lond B Biol Sci 1997; 352:1747-54
187. O'Hara MW, Ghoneim MM, Hinrichs JV, Mehta MP, Wright EJ: Psychological consequences of surgery. Psychosom Med 1989; 51:356-70
188. Popiela T, Kulig J, Hanisch J, Bock PR: Influence of a complementary treatment with oral enzymes on patients with colorectal cancers: An epidemiological retrolective cohort study. Cancer Chemother Pharmacol 2001; 47(suppl): S55-63
189. Sackeim HA, Stern Y: The neuropsychiatry of memory and amnesia, The American Psychiatric Press Textbook of Neuropsychiatry, 3rd edition. Edited by Yudofsky SC, Hales RE. Washington, DC, American Psychiatric Press, 1997, pp 501-18
190. Arrowsmith JE, Grocott HP, Reves JG, Newman MF: Central nervous system complications of cardiac surgery. Br J Anaesth 2000; 84:378-93
191. Millar K, Asbury AJ, Murray GD: Pre-existing cognitive impairment as a factor influencing outcome after cardiac surgery. Br J Anaesth 2001; 86:63-7
192. Roach GW: Pro: Prevention of neurologic dysfunction associated with cardiac surgery requires pharmacologic brain protection. J Cardiothorac Vasc Anesth 1997; 11:793-5
193. Fink M: Convulsive therapy: A review of the first 55 years. J Affect Disord 2001; 63:1-15
194. Donahue AB: Electroconvulsive therapy and memory loss: A personal journey. J ECT 2000; 16:133-43
195. Sackeim HA: Memory and ECT: From polarization to reconciliation (editorial). J ECT 2000; 16:87-96
196. Squire LR, Alvarez P: Retrograde amnesia and memory consolidation: A neurobiological perspective. Curr Opin Neurobiol 1995; 5:169-77
197. Hyman SE, Malenka RC: Addiction and the brain: The neurobiology of compulsion and its persistence. Nat Rev Neurosci 2001; 2:695-703
198. Everitt BJ, Dickinson A, Robbins TW: The neuropsychological basis of addictive behaviour. Brain Res (Brain Res Rev) 2001; 36:129-38
199. Miyata H, Yanagita T: Neurobiological mechanisms of nicotine craving. Alcohol 2001; 24:87-93
200. Block RI, Wittenborn JR: Marijuana effects on associative processes. Psychopharmacology 1985; 85:426-30
201. O'Leary DS, Block RI, Koeppel JA, Flaum M, Schultz SK, Andreasen NC, Boles Ponto L, Watkins GL, Hurtig RR, Hichwa RD: Effects of smoking marijuana on brain perfusion and cognition. Neuropsychopharmacology 2002; 26:802-16
202. Block RI, Ghoneim MM: Effects of chronic marijuana use on human cognition. Psychopharmacology 1993; 110:219-28
203. Block RI, O'Leary DS, Hichwa RD, Augustinack JC, Boles Ponto LL, Ghoneim AM, Arndt S, Hurtig RR, Watkins GL, Hall JA, Nathan PE, Andreasen NC: Effects of frequent marijuana use on memory-related regional cerebral blood flow. Pharmacol Biochem Behav 2002; 72:237-50
204. Rogers RD, Everitt BJ, Baldacchino A, Blackshaw AJ, Swainson R, Wynne K, Baker NB, Hunter J, Carthy T, Booker E, London M, Deakin JF, Sahakian BJ, Robbins TW: Dissociable deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to prefrontal cortex, and tryptophan-depleted normal volunteers: Evidence for monoaminergic mechanisms. Neuropsychopharmacology 1999; 20:322-39
205. Rosselli M, Ardila A: Cognitive effects of cocaine and polydrug abuse. J Clin Exp Neuropsychol 1996; 18:122-35
206. Beatty WW, Katzung VM, Moreland VJ, Nixon SJ: Neuropsychological performance of recently abstinent alcoholics and cocaine abusers. Drug Alcohol Depend 1995; 37:247-53
207. Beatty WW, Blanco CR, Hames KA, Nixon SJ: Spatial cognition in alcoholics: Influence of concurrent abuse of other drugs. Drug Alcohol Depend 1997; 44:167-74
208. Mittenberg W, Motta S: Effects of chronic cocaine abuse on memory and learning. Arch Clin Neuropsychol 1993; 8:477-83
209. Parsons OA, Prigatano GP: Memory functioning in alcoholics, Alcohol and Human Memory. Edited by Birnbaum IM, Parker ES. Hillsdale, New Jersey, Lawrence Erlbaum, 1977, pp 185-94
210. Cermak LS: The contribution of a "processing" deficit to alcoholic Korsakoff patients' memory disorder, Alcohol and Human Memory. Edited by Birnbaum IM, Parker ES. Hillsdale, New Jersey, Lawrence Erlbaum, 1977, pp 195-208
211. Bolla KI, Rothman R, Cadet JL: Dose-related neurobehavioral effects of chronic cocaine use. J Neuropsychiatry Clin Neurosci 1999; 11:361-9
212. Hoff AL, Riordan H, Morris L, Cestaro V, Wieneke M, Alpert R, Wang GJ, Volkow N: Effects of crack cocaine on neurocognitive function. Psychiatry Res 1996; 60:167-76
213. Robinson JE, Heaton RK, O'Malley SS: Neuropsychological functioning in cocaine abusers with and without alcohol dependence. J Int Neuropsychol Soc 1999; 5:10-9
214. Bolla KI, Funderburk FR, Cadet JL: Differential effects of cocaine and cocaine alcohol on neurocognitive performance. Neurology 2000; 54:2285-92
215. Rosenberg NL, Grigsby J, Dreisbach J, Busenbark D, Grigsby P: Neuropsychologic impairment and MRI abnormalities with chronic solvent abuse. J Toxicol 2002; 40:21-34
216. Parrott AC: Recreational ecstasy/MDMA, the serotonin syndrome, and serotonergic neurotoxicity. Pharmacol Biochem Behav 2002; 71:837-44
217. Morgan MJ, McFie L, Fleetwood H, Robinson JA: Ecstasy (MDMA): Are the psychological problems associated with its use reversed by prolonged abstinence? Psychopharmacologia 2002; 159:294-303
218. Dobbing J, Sands J: The brain growth spurt in various mammalian species. Early Hum Dev 1979; 3:79-84
219. Jevtovic-Todorovic V, Hartma RE, Izumi Y, Benshoff ND, Dikranian K, Zorumski CF, Olney JW, Wozniak DF: Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits. J Neurosci 2003; 23:876-82
220. Ikonomidou C, Bittigau P, Ishimaru MJ, Wozniak DF, Koch C, Genz K, Price MT, Stefovska V, Horster F, Tenkova T, Dikranian K, Olney JW: Ethanol-induced apoptotic neurodegeneration and fetal alcohol syndrome. Science 2000; 287:1056-60
221. Jevtovic-Todorovic V, Todorovic SM, Mennerick S, Powell S, Dikranian K, Benshoff N, Zorumski CF, Olney JW: Nitrous oxide (laughing gas) is an NMDA antagonist, neuroprotectant, and neurotoxin. Nat Med 1998; 4:460-3
222. Richardson GA, Ryan C, Willford J, Day NL, Goldschmidt L: Prenatal alcohol and marijuana exposure: Effects on neuropsychological outcomes at 10 years. Neurotoxicol Teratol 2002; 24:309-20
223. Dessens AB, Cohen-Kettenis PT, Mellenbergh GJ, Koppe JG, van De Poll NE, Boer K: Association of prenatal phenobarbital and phenytoin exposure with small head size at birth and with learning problems. Acta Paediatr 2000; 89:533-41
224. Streissguth AP, O'Malley K: Neuropsychiatric implications and long-term consequences of fetal alcohol spectrum disorders. Semin Clin Neuropsychiatry 2000; 5:177-90
225. Jernigan TL, Trauner DA, Hasselink JR, Tallal PA: Maturation of human cerebrum observed in vivo during adolescence. Brain 1991; 114:2037-49
226. Reiss AL, Abrams MT, Singer HS, Ross JL, Denckla MB: Brain development, sex and IQ in children: A volumetric imaging study. Brain 1996; 119:1763-74
227. Sowell ER, Peterson BS, Thompson PM, Welcome SE, Henkenius AL, Toga AW: Mapping cortical change across the human life span. Nat Neurosci 2003; 6:309-15
228. Wilson W, Mathew R, Turkington T, Hawk T, Coleman RE, Provenzale J: Brain morphological changes and early marijuana use: A magnetic resonance and positron emission tomography study. J Addict Disord 2000; 19:1-22
229. Landfield PW, Cadwallader LB, Vincent S: Quantitative changes in hippocampal structure following long-term exposure to delta-9-tetra hydrocannabinol: Possible mediation by glucocorticoid systems. Brain Res 1988; 443:47-62
230. Abraini JH: Inert gas and raised pressure: Evidence that motor decrements are due to pressure per se and cognitive decrements due to narcotic action. Eur J Physiol 1997; 433:788-91
231. Fowler B, Hendricks P, Porlier G: Effects of inert gas narcosis on rehearsal strategy in a learning task. Undersea Biomed Res 1987; 14:469-76
232. Taylor DM, O'Toole KS, Auble TE, Ryan CM, Sherman DR: The psychometric and cardiac effects of dimenhydrinate in the hyperbaric environment. Pharmacotherapy 2000; 20:1051-4
233. Zola SM, Squire LR: The medial temporal lobe and the hippocampus, The Oxford Handbook of Memory. Edited by Tulving E, Craik FIM. New York, Oxford University Press, 2000, pp 485-500
234. Moscovitch M, Winocur G: The frontal cortex and working with memory, Principles of Frontal Lobe Function. Edited by Stuss DT, Knight RT. London, Oxford University Press, 2000, pp 188-208
235. Moscovitch M: Confabulation and the frontal systems: Strategic versus associative retrieval in neuropsychological theories of memory, Varieties of Memory and Consciousness: Essays in Honour of Endel Tulving. Edited by Roedriger HL, Craik FIM. Hillsdale, NJ, Erlbaum 1989, pp 133-56
236. Glisky EL, Polster MR, Routhieaux BC: Double dissociation between item and source memory. Neuropsychology 1995; 9:229-35
237. Blennow K; Vanmechelen E; Hampel H: CSF total tau, Abeta42 and phosphorylated tau protein as biomarkers for Alzheimer's disease. Mol Neurobiol 2001; 24:87-97
238. Lynch G: Memory enhancement: The search for mechanism-based drugs. Nat Neurosci 2002; 5(suppl):1035-8
239. Doody RS, Stevens JC, Beck C, Dubinsky RM, Kaye JA, Gwyther L, Mohs RC, Thal LJ, Whitehouse PJ, DeKosky ST, Cummings JL: Practice parameter: Management of dementia (an evidence-based review): Report of the quality standards subcommittee of the American Academy of Neurology. Neurology 2001; 56:1154-66
240. Knopman DS, Morris JC: An update on primary drug therapies for Alzheimer disease. Arch Neurol 1997; 54:1406-9
241. Davies P, Maloney AJ: Selective loss of central cholinergic neurons in Alzheimer's disease (letter). Lancet 1976; 2:1403
242. Rasool CG, Svendsen CN, Selkoe DJ: Neurofibrillary degeneration of cholinergic and noncholinergic neurons of the basal forebrain in Alzheimer's disease. Ann Neurol 1986; 20:482-8
243. Kuhl DE, Koeppe RA, Minoshima S, Synder SE, Ficaro EP, Foster NL, Frey KA, Kilbourn MR: In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer's disease. Neurology 1999; 52:691-9
244. Wilkinson D: Drugs for treatment of Alzheimer's disease. Intl J Clin Pract 2001; 55:129-4
245. Hoozemans JJ, Rozemuller AJ, Veerhuis R, Eikelenboom P: The immunological aspects of Alzheimer's disease: Therapeutic implications. Biodrugs 2001; 15:325-37
246. Selkoe D: Amyloid beta-protein and the genetics of Alzheimer's disease. J Biol Chem 1996; 271:18295-8
247. Chen G, Chen KS, Knox J, Inglis J, Bernard A, Martin SJ, Justice A, McConlogue L, Games D, Freedman SB, Morris RG: A learning deficit related to age and beta-amyloid plaques in a mouse model of Alzheimer's disease. Nature 2000; 408:975-9
248. Janus C, Pearson J, McLaurin J, Mathews PM, Jiang Y, Schmidt SD, Chishti MA, Horne P, Heslin D, French J, Mount HT, Nixon RA, Mercken M, Bergeron C, Fraser PE, St George-Hyslop P, Westaway D: A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature 2000; 408:979-82
249. Morgan D, Diamond D, Gottschall PE, Ugen KE, Dickey C, Hardy J, Duff K, Jantzen P, DiCarlo G, Wilcock D, Connor K, Hatcher J, Hope C, Gordon M, Arendash GW: A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature 2000; 408:982-5
250. Wolozin B, Kellman W, Ruosseau P, Celesia GG, Siegel G: Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl co-enzyme A reductase inhibitors. Arch Neurol 2000; 57:1439-43
251. Bruno V, Battaglia G, Copani A, D'Onofrio M, Di Iorio P, De Blasi A, Melchiorri D, Flor PJ, Nicoletti F: Metabotropic glutamate receptor subtypes as targets for neuroprotective drugs. J Cereb Blood Flow Metab 2001; 21:1013-33
252. Buccafusco JJ, Terry AV Jr: Multiple central nervous system targets for eliciting beneficial effects on memory and cognition. J Pharmacol Exp Ther 2000; 295:438-46
253. Branchek TA, Blackburn TP: 5-HT6 receptors as emerging targets for drug discovery. Annu Rev Pharmacol Toxicol 2000; 40:319-34
254. Staubli U, Rogers G, Lynch G: Facilitation of glutamate receptors enhances memory. Proc Natl Acad Sci U S A 1994; 91:777-81
255. Barco A, Alarcon JM, Kandel ER: Expression of Constitutively active CREB protein facilitates the late phase of long-term potentiation by enhancing synaptic capture. Cell 2002; 108:689-703
256. Pardridge WM: Blood-brain barrier drug targeting: The future of brain drug development. Mol Interventions 2003; 3:90-105